FDAnews
www.fdanews.com/articles/73842-cougar-licenses-rights-to-seocalcitol-from-leo

COUGAR LICENSES RIGHTS TO SEOCALCITOL FROM LEO

June 29, 2005

Cougar Biotechnology, a privately held biotechnology company, today announced that it has licensed the worldwide, exclusive rights to seocalcitol from Dutch firm LEO Pharma A/S. Seocalcitol (EB1089) is a synthetic analog of vitamin D that has been clinically tested in a number of different cancer indications. The results of in vivo and in vitro studies have shown that vitamin D and analogs of vitamin D have anticancer activity in a wide range of tumor types.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1001241XSL_NEWSML_TO_NEWSML_WEB.xml)